Clinical trial
Efficacy of Tranexamic Acid (TXA) in Humerus ORIF
NCT05802238 is registered in ClinicalTrials.gov with Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Tranexamic Acid (TXA) in Humerus ORIF
- Lead sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- April 12, 2023
- Completion date
- November 25, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fracture humerus